Sign in
Enrolling by invitationNo phase

Online lifestyle program for weight management and heart health

Tests a 90-day online exercise, supplement and education program in adults with heart risk factors.

Key facts

Who runs it
Truemedicine Inc
Where
San Francisco, United StatesSee the site
Trial code
Registry title
Virtual Lifestyle Intervention for Weight Management and Cardiovascular Heal
Status
Enrolling by invitation
People taking part
200 people, planned
Started
10 Apr 2026
Planned end
1 Oct 2026
Type of study
Interventional
Treatments tested
  • Multicomponent Virtual Lifestyle Intervention
Record updated
7 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 30 to 60 with a stable weight, a sedentary lifestyle and several heart-health risk signs. It runs fully online for 90 days.

Age
30 to 60 years
Sex
All sexes can join.
Disease stage
At least 3 of 5 heart-health risk signs: large waist (35 inches or more for women, 40 inches or more for men), blood pressure 130/85 mmHg or higher, fasting glucose 100 mg/dL (5.6 mmol/L) or higher or HbA1c 5.7% (39 mmol/mol) or higher, triglycerides 150 mg/dL (1.7 mmol/L) or higher, low HDL cholesterol (below 40 mg/dL (1 mmol/L) for men, below 50 mg/dL (1.3 mmol/L) for women).
Earlier treatment
Must not be in any formal weight loss or weight management program. Weight change of no more than 5 pounds (2.3 kg) in the past 3 months.

Main reasons for not taking part

  • Type 2 diabetes treated with medicine where unsupervised exercise could be risky
  • Untreated, clinically significant sleep apnea where unsupervised exercise could be risky
  • Taking investigational drugs or in another interventional study
  • Pregnant or breastfeeding
  • Unwilling to use Peloton equipment or get a Peloton digital membership

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Adults aged 30 to 60 years at the time of enrollment Stable body weight, defined as no change of more than 5 pounds (2.3 kg) in the three months prior to enrollment Sedentary lifestyle, defined as fewer than 60 minutes of structured exercise per week Not currently participating in any formal weight loss or weight management program Current owner of at least one compatible wearable fitness or health tracking device (Garmin, Fitbit, Apple Watch, Oura Ring, or Whoop) Access to Peloton equipment or willingness to obtain a Peloton digital membership for the duration of the study Must meet the cardiovascular risk profile threshold (minimum of three of five criteria: waist circumference ≥35 inches (women) or ≥40 inches (men), most recent systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg, most recent fasting glucose ≥100 mg/dL or HbA1c ≥5.7%, most recent triglycerides ≥150 mg/dL, most recent HDL cholesterol <40 mg/dL (men) or <50 mg/dL (women)) Able to read and understand English Willing to provide informed consent electronically Willing and able to complete all digital study activities, surveys, and assessments using the Alethios platform Willing and able to collect at-home dried blood spot (DBS) samples using a provided kit at three designated timepoints

Who cannot take part

  • Diagnosis of type 2 diabetes requiring pharmacological management where participation in unsupervised exercise would pose risk, as determined by the investigator Untreated, clinically significant sleep apnea where unsupervised aerobic exercise participation could pose risk Any medical condition or circumstance that, in the opinion of the investigator, would make participation unsafe or interfere with data quality Unwillingness to use Peloton equipment or obtain a Peloton digital membership Current use of investigational drugs or participation in another interventional research study during the study period Pregnant or breastfeeding individuals Individuals unable to provide informed consent

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 60 years old?

Where in United States

  • AlethiosSan Francisco, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This is a 90-day, single-arm, open-label, fully virtual community lifestyle intervention study evaluating the effects of a multicomponent lifestyle intervention on weight management and cardiovascular health. Participants will engage in structured aerobic exercise via the Peloton platform, take daily supplements (Omega-3, Vitamin D3, Magnesium Malate, and fiber), use wearable devices for activity and sleep tracking, and receive structured educational content. The study is conducted entirely remotely using the Alethios digital research platform.

The group in the trial

  • Multicomponent Lifestyle InterventionTreatment being tested

    Single arm receiving a 90-day multicomponent lifestyle intervention including structured aerobic exercise via Peloton platform, daily supplementation with Omega-3 (2400 mg/day), Vitamin D3 (4,000 IU/day), Magnesium Malate (440 mg/day), and fiber (6g/day), wearable-based activity and sleep tracking, and structured educational content.

    Treatment: Multicomponent Virtual Lifestyle Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A 90-Day, Single-Arm, Open-Label, Fully Virtual Community Lifestyle Intervention Study Evaluating the Effects of a Multicomponent Lifestyle Intervention on Weight Management and Cardiovascular Health
Plain-language title
Online lifestyle program for weight management and heart healthGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Criteria questions
Built from NCT07572721, who can take part
Record updated
7 May 2026